<DOC>
	<DOCNO>NCT02386007</DOCNO>
	<brief_summary>The purpose study find optimum dosage DW-3101 evaluate efficacy safety dosage group Korean patient acute chronic gastric inflammation .</brief_summary>
	<brief_title>Phase 2a Study Evaluate Optimum Dosage Stability DW-3101 Gastric Inflammation Patients</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<criteria>Adult males/females age 20~75 year Patients detect 1 erosion diagnose acute chronic gastric inflammation gastrscopy 7days administration experimental agent Subjects voluntarily agree participate clinical test write consent Patients impossible gastroscopy In case accompany gastric ulcer ( scar except ) reflux esophagitis Patients stomach esophagus surgery inhibit gastric acid secretion ( tresis appendicectomy surgery exclude ) Patients malignant tumor digestive organ Patients blood clot ( cerebral thrombosis , myocardial infarction , septic thrombophlebitis ) antithrombotic agent ( eg . warfarin )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>